CNBC's Angelica Peebles talks to Structure Therapeutics CEO Ray Stevens about the obesity landscape and why there's still ...

"As anyone who has experienced a cancer diagnosis will know, it takes time to adjust to a new normal," the Princess of Wales ...

Greg Lipschitz, Executive Chairman of Firefly, said, “This breakthrough underscores our commitment to pushing the boundaries of innovation in brain health, ultimately with the aim of making a ...

A new study finds that dementia cases are expected to double to 1 million by 2060, with African-American cases potentially ...

Our study results forecast a dramatic rise in the burden from dementia in the United States over the coming decades,” said ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

Learn about the types of providers who treat patients with age-related cognitive decline and dementia and how to get the most out of your initial visit.

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

I have a special interest in Alzheimer’s disease. For nearly 25 years, I practiced general neurology in Portland, Oregon, and ...

For a person living with dementia, being able to use language and communicate clearly can become more difficult over time. While the person living with the condition may have difficulties finding the ...

These 11 stories offer expert advice on dementia and Alzheimer’s, as well as ways to help prevent it. Photo / 123rf Research suggests certain characteristics may be linked with the disease.

Emraclidine is under clinical development by Cerevel Therapeutics and currently in Phase I for Dementia Associated With Alzheimer’s Disease. According to GlobalData, Phase I drugs for Dementia ...